HinduPost is the voice of Hindus. Support us. Protect Dharma

Will you help us hit our goal?

HinduPost is the voice of Hindus. Support us. Protect Dharma
-4.7 C
Friday, December 8, 2023

Shot in the arm: Vaccination for 15-18 age group from Jan 3

Prime Minister Narendra Modi announced on Saturday that Covid vaccination for the 15-18 age group will commence from January 3, 2022, while healthcare/frontline workers, along with the 60+ population with comorbidities, will get a precautionary dose from January 10 onwards next year.

“The decision to vaccinate children will not only strengthen our fight against Covid-19, rather it would also reduce the worries of the parents whose children are going to schools,” the Prime Minister said in his televised address to the nation.

The country is currently staring at a possible third wave of Covid-19 amid growing concerns over the spread of the new strain — Omicron.

As the elderly and people with comorbidities are more vulnerable to catch serious illness from the Omicron strain, Modi also announced a precautionary dose for them.

“Those with comorbidities and above 60 years of age will be eligible for a precautionary dose from January 10, 2022 onwards on the recommendation of their doctors,” Modi said.

In his message to the nation, the Prime Minister also urged people not to panic amid growing concerns over the Omicron variant, and appealed to everyone to stay alert, wash hands and make full use of masks.

Notably, the Hyderabad-based vaccine manufacturer Bharat Biotech’s Covaxin on Saturday got approval from the Drug Controller General of India (DCGI) for emergency use for the 12-18 age group.

The vaccine manufacturer had submitted data from clinical trials in the 12-18 age group for Covaxin (BBV152) to the Central Drugs Standard Control Organisation (CDSCO). Bharat Biotech had said earlier that the data was reviewed by the CDSCO and the Subject Experts Committee (SEC), which provided their positive recommendations.

(The story has been published via a syndicated feed with a modified headline)

Subscribe to our channels on Telegram &  YouTube. Follow us on Twitter and Facebook

Related Articles


Please enter your comment!
Please enter your name here


Latest Articles

Sign up to receive HinduPost content in your inbox
Select list(s):

We don’t spam! Read our privacy policy for more info.

Thanks for Visiting Hindupost

Dear valued reader, has been your reliable source for news and perspectives vital to the Hindu community. We strive to amplify diverse voices and broaden understanding, but we can't do it alone. Keeping our platform free and high-quality requires resources. As a non-profit, we rely on reader contributions. Please consider donating to Any amount you give can make a real difference. It's simple - click on this button:
By supporting us, you invest in a platform dedicated to truth, understanding, and the voices of the Hindu community. Thank you for standing with us.